Measles in Pregnancy – Clinical & Patient Resources
Measles remains a serious threat to pregnant individuals due to its potential maternal and fetal complications. The Society for Maternal-Fetal Medicine (SMFM) offers timely, evidence-based resources to support clinicians in diagnosis, treatment, and prevention, and to equip patients with trusted educational tools.
Clinician Resources
- Provider FAQs: Measles in Pregnancy (Updated July 2025)
- Administer IVIG within 6 days post-exposure for non-immune pregnant individuals
- Avoid Vitamin A doses used for measles treatment during pregnancy
- MMR vaccine should be deferred until postpartum in unimmunized pregnant persons
- MMR is safe during breastfeeding; postpartum isolation may be needed after infection
- Provider Infographic (2024)
- 2025 Measles Call to Action
Partner & External Resources
Reliable, external sources for further information:
-
Government Resources
- CDC April 2025 Morbidity and Mortality Weekly Report on Measles
- CDC Be Ready For Measles Toolkit
- CDC Communications and Public Health Resources on Measles
- CDC Healthcare Providers Measles Page
- CDC Healthcare Systems Preparedness Checklist (last page)
- CDC HAN March 2024 on Measles
- CDC HAN March 2025 on Measles
- CDC Measles Cases and Outbreaks in the US
Partner Organization Resources
Online Learning & Webinars
Additional Resources
Patient Resources
Learn how measles can affect pregnancy, how to protect your patients, and when patients need to seek care.
Measles in Pregnancy: Infographic
MMR Vaccine Flowchart
Publications & Guidelines
Access joint publications, statements from SMFM, white papers, and more.